Advanced search
Publication Cover
Journal of Chemotherapy Volume 1, 1989 - Issue 4
Submit an article Journal homepage
1
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Low Dose Intermittent 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) in Poor Risk Patients with Advanced Transitional Cell Bladder Cancer: a Pilot Study

G. LelliOncology Department, S. Orsola-Malpighi Hospital, Bologna.
,
A. TononiOncology Department, S. Orsola-Malpighi Hospital, Bologna.
,
P. BacchettiI Urology Department, S. Orsola-Malpighi Hospital, Bologna.
,
P. MaverI Urology Department, S. Orsola-Malpighi Hospital, Bologna.
,
G. CorradoI Urology Department, S. Orsola-Malpighi Hospital, Bologna.
,
F. GarofaloII Urology Department, S. Orsola-Malpighi Hospital, Bologna.
,
P. De SantisII Urology Department, S. Orsola-Malpighi Hospital, Bologna.
&
F. PannutiOncology Department, S. Orsola-Malpighi Hospital, Bologna.
 show all
Pages 269-271 | Published online: 14 Jul 2016

References

  • Sternberg C, Scher HI. Advances in the treatment of urothelial tract tumors. Urol Clin North Am 1987; 14: 373–387.
  • Gagliano RG, Stephens RL, Costanzi JJ, et al. Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study. Cancer Treat Rep 1984; 68: 1025–1026.
  • Smalley RV, Bartolucci AA, Hemstret G, Hester M. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin, and 5-fluorouracil and of fluorouracil in patients with advanced bladder carcinoma or stage D prostate cancer. J Urol 1981; 125: 191–195.
  • Kotake T, Usami M, Miki T, Koruda M, Obaka K, Osafune M. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract. Cancer Chemother Pharmacol 1983; 2: 538–542.
  • Maru A, Akaza H, Isaka S, Koiso K, Kotake T. Phase III trial of the Japanese urological cancer research group for adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder. Cancer Chemother Pharmacol 1987; 20: 544–548.
  • Gehan E, Schneidermann. Experimental design of clinical trials. In: Holland J.F. and Frei E. (Eds.), Cancer Medicine, Philadelphia: Lea and Febiger 1982: 531–553.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.